Lee et al developed a nomogram for predicting gastric cancer associated with peptic ulcer disease. This can help to identify a patient who should be screened for the disease. The authors are from multiple institutions in Taiwan.
Patient selection: adult with peptic ulcer disease in Taiwan
Outcome: 2-year risk of gastric cancer
Parameters:
(1) age
(2) gender
(3) ulcer sites
(4) peptic ulcer complications
(5) H. pylori eradication
(6) duration of NSAID use in the 3 months before hospitalization
(7) upper GI follow-up indicated
Age Range |
Points |
40 to 65 |
(-0.06135 * ((age)^2)) + (8.209 * (age)) -230.5 |
65 to 85 |
(-0.07029 * ((age)^2)) + (12.16 * (age)) - 450.2 |
85 to 110 |
(0.2465 * (age)) + 54.1 |
Parameter |
Finding |
Points |
gender |
female |
0 |
|
male |
16.8 |
peptic ulcer sites |
duodenum |
0 |
|
gastric and duodenum |
38 |
|
gastric |
75.6 |
complications |
no |
0 |
|
yes |
20.4 |
H. pylori eradicated |
no |
23.5 |
|
yes |
0 |
NSAID duration |
never used |
85.3 |
|
1 month |
57 |
|
2 months |
28.5 |
|
3 months |
0 |
follow-up indicated |
no |
0 |
|
yes |
100 |
The NSAID duration can be represented as:
points for NSAIDS =
= (85.36 - (28.44 * (duration in months))
total score =
= SUM(points for all 7 parameters)
Interpretation:
• minimum score: 0
• maximum score: 402.8
• The higher the score the greater the risk of gastric cancer.
Total Score |
2-Year Percent with Gastric Cancer |
< 260 |
< 0.5% |
260 to 302 |
(0.0117096 * (score)) - 2.54098 |
302 to 402.8 |
(0.0002897 * ((score)^2)) - (0.1665 * (score)) + 24.87 |
Specialty: Hematology Oncology, Gastroenterology